Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $2.15 billion. The enterprise value is $1.57 billion.
Important Dates
The next estimated earnings date is Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 218.96 million shares outstanding. The number of shares has increased by 19.87% in one year.
| Current Share Class | 218.96M |
| Shares Outstanding | 218.96M |
| Shares Change (YoY) | +19.87% |
| Shares Change (QoQ) | +0.53% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 79.99% |
| Float | 184.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.40 |
| Forward PS | 39.65 |
| PB Ratio | 3.70 |
| P/TBV Ratio | 3.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 30.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.81, with a Debt / Equity ratio of 0.14.
| Current Ratio | 14.81 |
| Quick Ratio | 14.49 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.75 |
Financial Efficiency
Return on equity (ROE) is -68.55% and return on invested capital (ROIC) is -37.31%.
| Return on Equity (ROE) | -68.55% |
| Return on Assets (ROA) | -32.88% |
| Return on Invested Capital (ROIC) | -37.31% |
| Return on Capital Employed (ROCE) | -43.72% |
| Weighted Average Cost of Capital (WACC) | 9.26% |
| Revenue Per Employee | $160,117 |
| Profits Per Employee | -$893,840 |
| Employee Count | 325 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 64.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.07% in the last 52 weeks. The beta is 0.90, so OCUL's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +7.07% |
| 50-Day Moving Average | 9.12 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 60.51 |
| Average Volume (20 Days) | 3,169,082 |
Short Selling Information
The latest short interest is 25.09 million, so 11.46% of the outstanding shares have been sold short.
| Short Interest | 25.09M |
| Short Previous Month | 24.78M |
| Short % of Shares Out | 11.46% |
| Short % of Float | 13.61% |
| Short Ratio (days to cover) | 8.74 |
Income Statement
In the last 12 months, OCUL had revenue of $52.04 million and -$290.50 million in losses. Loss per share was -$1.45.
| Revenue | 52.04M |
| Gross Profit | -175.06M |
| Operating Income | -299.44M |
| Pretax Income | -290.50M |
| Net Income | -290.50M |
| EBITDA | -294.82M |
| EBIT | -299.44M |
| Loss Per Share | -$1.45 |
Full Income Statement Balance Sheet
The company has $666.70 million in cash and $79.46 million in debt, giving a net cash position of $587.24 million or $2.68 per share.
| Cash & Cash Equivalents | 666.70M |
| Total Debt | 79.46M |
| Net Cash | 587.24M |
| Net Cash Per Share | $2.68 |
| Equity (Book Value) | 581.57M |
| Book Value Per Share | 2.66 |
| Working Capital | 658.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$226.21 million and capital expenditures -$14.74 million, giving a free cash flow of -$240.94 million.
| Operating Cash Flow | -226.21M |
| Capital Expenditures | -14.74M |
| Depreciation & Amortization | 4.63M |
| Net Borrowing | n/a |
| Free Cash Flow | -240.94M |
| FCF Per Share | -$1.10 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | -575.43% |
| Pretax Margin | -558.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.87% |
| Shareholder Yield | -19.87% |
| Earnings Yield | -13.48% |
| FCF Yield | -11.18% |
Analyst Forecast
The average price target for OCUL is $27.09, which is 175.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.09 |
| Price Target Difference | 175.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 80.16% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 5.3 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.3 |
| Piotroski F-Score | 2 |